Shares in Danish drugmaker Novo Nordisk dropped as much as 5.3% on Friday, set for their biggest one-day fall since August 2022, after rival Amgen said it was encouraged by interim trial data on its experimental obesity drug. Novo Nordisk were last down 4.4% by 1022 GMT, having hit their lowest in two months earlier in the day. Amgen on Thursday said it was very encouraged after completing an interim analysis of its mid-stage study of experimental weight-loss drug MariTide, which, if approved, would compete Novo's Wegovy and Eli Lilly's Zepbound.
Jeremy Clarkson's farm manager is shown suffering a nasty injury in season three of the show - caused by equipment that was supposed to keep him safe.
Thru | Total | Purse | ||
---|---|---|---|---|
F | -12 | $562,500 | ||
F | -9 | $341,488 | ||
F | -6 | $247,725 | ||
F | -5 | $172,940 | ||
F | -5 | $172,940 | ||
F | -4 | $115,917 | ||
F | -4 | $115,917 | ||
F | -3 | $77,402 | ||
F | -3 | $77,402 | ||
F | -3 | $77,402 |